4.5 Article

C-reactive protein induces G2/M phase cell cycle arrest and apoptosis in monocytes through the upregulation of B-cell translocation gene 2 expression

期刊

FEBS LETTERS
卷 588, 期 4, 页码 625-631

出版社

WILEY
DOI: 10.1016/j.febslet.2014.01.008

关键词

C-reactive protein; Monocytes; p53; B-cell translocation gene 2; Apoptosis; Atherogenesis

资金

  1. Korean Ministry of Health and Welfare [A050020]
  2. Asan Institute for Life Sciences [2011-288]
  3. Korea Science and Engineering Foundation (KOSEF) [C00058, M10748000263-07N4800-26310]
  4. Korea government (MOST)
  5. Dong-a research fund
  6. Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080016]
  7. Basic Science Research Program through the National Research Foundation of Korea (NRF)
  8. Ministry of Education, Science and Technology [2009-0072141]
  9. NRF, MEST, Korea [20110027584]
  10. Korea Health Promotion Institute [A080016, A050020] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  11. National Research Foundation of Korea [2009-0072141] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

We hypothesized that C-reactive protein (CRP) may affect the cell cycle and induce apoptotic changes of monocytes. CRP (similar to 25 mu g/ml) significantly increased expressions of B-cell translocation gene 2 (BTG2) mRNA and protein in human monocytes through pathways involving CD32/NADPH oxidase 2/p53, which eventually induced G2/M phase arrest and apoptotic cell death. Such pro-apoptotic effect of CRP was not found in thioglycollate-elicited intraperitoneal monocytes/macrophages harvested from BTG2-knockout male C57BL/6 mice (n = 5). Within atheromatous plaques obtained from CRP-transgenic male LDLR (/) C57BL/6 mice (n = 5) and human coronary arteries, BTG2 co-localized with CRP, p53 and monocytes/macrophages. Therefore the pro-apoptotic pathway of CRP-CD32-Nox2-p53-BTG2 may contribute to the retardation of the atherogenic process. (C) 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据